Concerto HealthAI announced today that they have entered into a collaboration with Pfizer to advance work …
Read More »
FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 11, 2019– Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from the …
Read More »
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
JUPITER, FL – November 21, 2016 – While there have been advances in the treatment …
Read More »
A study led by researchers at the University of Birmingham reveals the key role of …
Read More »
TORONTO, ON–(Marketwired – November 21, 2016) – Toronto-based MaRS Innovation announced today that one of …
Read More »
DUBLIN, Nov. 22, 2016 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, …
Read More »
INDIANAPOLIS, Nov. 23, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that …
Read More »
AstraZeneca today announced that the US FDA has lifted the partial clinical hold on the …
Read More »
SAN DIEGO, Nov. 21, 2016 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that …
Read More »SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune …
Read More »
Hepatitis C treatment options continue to be a vibrant field full of exciting research, including …
Read More »
Basel, November 21, 2016 – Novartis today announced it has acquired Selexys Pharmaceuticals Corporation, a …
Read More »
Paris, France – November 21, 2016 – Sanofi announced today that the U.S. Food and …
Read More »
Copenhagen, Denmark; November 21, 2016 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today the U.S. …
Read More »
PLAINSBORO, N.J., Nov. 21, 2016 /PRNewswire/ — Novo Nordisk, a world leader in diabetes care, today …
Read More »
Researchers leading the largest genomic tumor profiling effort of its kind say such studies are …
Read More »
INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced new data from the Phase I INVICTAN®-1 study, which …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
